Back to
ExodusPoint Capital Management, LP
IOVA
Showing 6 of 21 quarters
Position history for
ExodusPoint Capital Management, LP's holdings in Iovance Biotherapeutics, Inc.
Yes. ExodusPoint Capital Management holds 270,655 shares of IOVA (Iovance Biotherapeutics), worth $1.1M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$1.1M
Current Shares
270,655
Total Value Change
-$2.8M
Total Shares Change
-900,090
Quarter-by-Quarter History